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Voxel-based morphometry (VBM)In multiple system atrophy with predominant parkinsonism (MSA-P), several voxel-based morphometry
(VBM) studies have revealed gray matter loss; however, the white matter volume changes have been rarely
reported. We investigated the volume changes of white matter as well as gray matter by VBM. A retrospective
MRI study was performed in 20 patients with MSA-P and 30 age-matched healthy controls. We applied VBM
with statistical parametric mapping (SPM8) plus diffeomorphic anatomical registration through
exponentiated Lie algebra (DARTEL) to explore the regional atrophy of gray and white matter in all of the
MSA-P patients, 14 patients with left-side dominant and 6 patients with right-side dominant onset as com-
pared to controls. In all of the MSA-P patients, VBM revealed a signiﬁcant volume reduction of gray matter
in the bilateral putamina, cerebellums and dorsal midbrain. White matter loss was located in bilateral globus
pallidi, external capsules extending to the midbrain, right subcortical to precentral area through internal cap-
sule, the pons, bilateral middle cerebellar peduncles and left cerebellum. In left-side dominant MSA-P pa-
tients, the gray and white matter volume loss was detected predominantly on the right side and vice versa
in right-side dominant MSA-P patients. A correlation with disease duration and severity was not detected.
VBM using SPM8 plus DARTEL detected signiﬁcant volume loss not only in the gray but also in the white mat-
ter of the area affected by MSA-P.
© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY license.1. Introduction
MSA is a sporadic, progressive, neurodegenerative disorder clinically
characterized by autonomic dysfunction, parkinsonism, cerebellar atax-
ia, and pyramidal signs (Quinn, 1989). MSA can be classiﬁed into two
subgroups, a cerebellar (MSA-C) and a parkinsonian (MSA-P) variant
(Gilman et al., 2008). Neuropathologically, MSA is characterized by
selective neuronal loss and reactive gliosis predominantly affecting
the basal ganglia, substantia nigra, olivopontocerebellar pathways and
the intermediolateral cell column of the spinal cord (Papp and Lantos,
1994; Wenning et al., 1997). The histological hallmarks of MSA areira, Tokyo 187-8551, Japan.
.
nc. Open access under CC BY license.α-synuclein-positive glial cytoplasmic inclusions in the oligoden-
droglia, which are required for the diagnosis of deﬁnite MSA (Gilman
et al., 2008; Papp and Lantos, 1994; Wenning et al., 1997).
VBM is a method of statistically analyzingmorphological changes in
the brain asmeasured bywhole-brainMRI data (Ashburner and Friston,
2000). In the past few years, VBM has been used to study the patterns
of structural changes in the brain during brain development or in
neurodegenerative disorders (Bergﬁeld et al., 2010; Brenneis et al.,
2004; Burton et al., 2002). In MSA-P, VBM revealed gray matter loss
mainly in the striatum, the cerebral cortex including the motor area
and the cerebellar lobes (Brenneis et al., 2003, 2007; Minnerop et al.,
2007; Tir et al., 2009; Tzarouchi et al., 2010). However, white matter
volume changes have been rarely reported, and the results were
inconsistent (Brenneis et al., 2003; Minnerop et al., 2007, 2010;
Tzarouchi et al., 2010).
In the present study, we evaluated MR images of MSA-P patients
to examine the volume changes of white matter as well as gray
matter by using the latest VBM technique with SPM 8 plus DARTEL
(Matsuda et al., 2012).
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2.1. Participants
We retrospectively reviewed an electronic database of radiology
reports for 12,029 patients who underwent brain MRI examinations
at our institution between March 2007 and September 2010 and
searched for reports that indicated Parkinson's disease and related
disorders. After 127 patients were indicated by the radiological reports,
medical records revealed 23patientswhowere diagnosed as possible or
probable MSA-P according to consensus criteria (Gilman et al., 2008).
Among 23 patients, three patients were excluded because of the pres-
ence of multiple lacunar infarctions in two patients and multiple
cavernous hemangiomas in one patient. All volumetric T1-weighted
images were visually inspected for apparent artifacts due to patient
motion or metallic dental prostheses. As a consequence, 20 patients
(7 men and 13 women; age range 48–77 years, mean age 62.9 ±
7.7 years, disease duration 4.1 ± 2.2 years) were enrolled as subjects
in this study. The patient data are given in Table 1. Among these
patients, 14 patients had left-side dominant (5 men and 9 women;
age range 53–77 years, mean age 64.1 ± 6.4 years, disease duration
4.2 ± 2.5 years) and 6 patients had right-side dominant onset symp-
toms (2 men and 4 women; age range 48–73 years, mean age 59.8 ±
10.0 years, disease duration 3.7 ± 1.2 years). As a measure of disease
severity, we adopted the following disease stages previously described:
stage 0 = no gait difﬁculties, stage 1 = disease onset, as deﬁned by
onset of gait difﬁculties, stage 2 = loss of independent gait, as deﬁned
by permanent use of a walking aid or reliance on a supporting arm,
stage 3 = conﬁnement to wheelchair, as deﬁned by permanent use of
a wheelchair (Klockgether et al., 1998).
Our local ethics committee did not require approval or patient
informed consent for the retrospective review. Thirty age-matched
control subjects (10 men and 20 women; age range 48–80 years, mean
age 64.7 ± 7.7 years) were also involved as healthy control subjects.
Thirty age-matched healthy controls (10 men and 20 women; age
range 48–80 years, mean age 64.7 ± 7.7 years) were also involved as
control subjects. None had a history of neurological or psychiatric
illness, and no abnormalities were observed on their brain structural
MRIs. Institutional review board approval and written informed
consent were obtained from the control subjects.
2.2. Image acquisition and analysis
All examinations were performed with a 1.5 T MR imaging system
(Symphony Vision; Siemens, Erlangen, Germany). MR protocol forTable 1
Demographic characteristics of MSA-P patients and controls.
Characteristic MSA-P Controls
Age (y) 62.9 ± 7.7 (48–77) 62.9 ± 7.7 (48–80)
Sex 7 men, 13 women 10 men, 20
women
Diagnosis 16 probable MSA-P, 4 possible
MSA-P
Disease duration (y) 4.1 ± 2.2 (2–10)
Stage 1 6
Stage 2 11
Stage 3 3
Cerebellar symptoms 7 present, 13 absent
Pyramidal signs 7 present, 13 absent
Urinary incontinence 15 present, 5 absent
Orthostatic
hypotension
13 present, 7 absent
Note: Unless otherwise indicated, data are means ± standard deviations, with ranges
in parentheses. Stage 0 = no gait difﬁculties, stage 1 = disease onset, as deﬁned by
onset of gait difﬁculties, stage 2 = loss of independent gait, as deﬁned by permanent
use of a walking aid or reliance on a supporting arm, stage 3 = conﬁnement to
wheelchair, as deﬁned by permanent use of a wheelchair.the parkinsonian is as follows. High-resolution three-dimensional
(3D) T1-weighted images were acquired using magnetization-prepared
rapid acquisition of a gradient echo sequence (144 sagittal sections,
TR = 1600 ms, TE = 2.6 ms, ﬂip angle = 15°, voxel size =
1.2 × 1.2 × 1.2 mm3, FOV = 315 mm, matrix = 208 × 256, 1.2-mm
thickness with no gap). Axial T2-weighted images (TR = 3800 ms,
TE = 95 ms, ﬂip angle = 150°, voxel size = 0.7 × 0.4 × 5.0 mm3,
FOV = 230 mm, matrix = 281 × 512, 5-mm thickness with 1.8-mm
gap) and coronal ﬂuid attenuation inversion recovery images
(TR = 9000 ms, TE = 100 ms, ﬂip angle = 170°, voxel size =
1.2 × 0.9 × 5.0 mm3, FOV 230 mm,matrix = 192 × 256, 5.0-mm thick-
ness with 1.8-mm gap) were also obtained.
Using the latest version of SPM8 (Wellcome Department of Imaging
Neuroscience, London, United Kingdom), we segmented the MRIs into
gray matter, white matter, and cerebrospinal ﬂuid images by a uniﬁed
tissue-segmentation procedure after image-intensity nonuniformity
correction. These segmented gray and white matter images were then
spatially normalized to the customized template in the standardized
anatomic space by using DARTEL (Wellcome Department of Imaging
Neuroscience) (Ashburner, 2007). To preserve the gray and white
matter volumes within each voxel, we modulated the images using
the Jacobean determinants derived from the spatial normalization by
DARTEL and then smoothed them using an 8-mm FWHM Gaussian
kernel.
Morphological group differences for these smoothed gray and
white matter images between all of the MSA-P patients and the
controls were analyzed using a 2-sample t-test in SPM8. The same
analysis was performed between the 14 left-side dominant onset
MSA-P patients and the controls and between the 6 right-side domi-
nant onset MSA-P patients and the controls. Group comparisons by
SPM8 were assessed using the false discovery rate at a threshold of
p b .05, corrected for multiple comparisons.
Additionally, for the correlation analyses with disease duration
and disease stage, we used a multiple regression analysis and an
uncorrected threshold of p b .001.
3. Results
In MSA-P patients, VBM revealed regions of gray matter loss bilat-
erally affecting the putamina, cerebellums, dorsal midbrain and left
inferior occipital gyrus (see Table 2, Fig. 1). Reduced white matter
volume was located in the bilateral globus pallidi and external
capsules extending to the midbrain (see Table 3, Fig. 2). On the
right side, it extended upward to the subcortical to precentral area
through the internal capsule. White matter loss in the pons, bilateral
middle cerebellar peduncles and left cerebellum was also detected. In
left-side dominant MSA-P patients, the putaminal gray matter was
decreased only on the right side (see Table 4, Fig. 3). The reduced
white matter was located in the right globus pallidus and external
capsule (see Table 5, Fig. 3). In right-side dominant MSA-P patients,
gray matter was reduced in the left putamen, bilateral cerebellumsTable 2
Clusters of gray matter loss (20 MSA-P vs. 30 controls).
Region volume
(mm3)
Z score Talairach coordinates
(x, y, z)
Location of local
maxima
9680 4.46 40, −46, −36 Right cerebellar tonsil
3.79 36, −69, −15 Right cerebellum
3.55 24, −46, −13 Right cerebellum
8424 6.36 26, 14, 7 Right putamen
6960 4.31 −40, −54, −23 Left cerebellum
3.6 −28, −84, −9 Left inferior occipital gyrus
3.31 −20, −75, −20 Left cerebellum
5712 6.05 −26, 8, 7 Left putamen
3896 4.6 0, −34, −12 Dorsal midbrain
Voxel size 2 × 2 × 2 mm3. Clusters of gray matter SPM analysis with FDR-corrected at
p b .05 are shown. The coordinates refer to the Talairach reference space.
Fig. 1. Comparison of gray matter volume by VBM using SPM8 plus DARTEL among 20 patients with MSA-P and 30 control subjects. Signiﬁcant atrophy is observed in the bilateral
putamina, cerebellums, dorsal midbrain and left inferior occipital gyrus in MSA-P patients compared to controls. Results are superimposed on the customized gray matter template
(FDR-corrected at p b .05).
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matter was located in the left globus pallidus, bilateral external
capsules, right frontal lobe, right parahippocampal area and right
cerebellum (see Table 7, Fig. 4). A correlation with disease duration
and severity was not detected.Table 3
Clusters of white matter loss (20 MSA-P vs. 30 controls).
Region volume
(mm3)
Z score Talairach coordinates
(x, y, z)
Location of local
maxima
32,144 4.23 −12, −64, −34 Left cerebellum
4.12 −16, −27, −32 Left pons
4.07 −16, −38, −22 Left cerebellum
20,360 5.46 32, −10, 2 Right external capsule
4.94 18, 2, −5 Right lateral globus pallidus
3.35 36, −6, 32 Right sub-precentral area
10,272 5.04 −34, −8, 4 Left external capsule
4.79 −20, −2, −5 Left lateral globus pallidus
Voxel size 2 × 2 × 2 mm3. Clusters of gray matter SPM analysis with FDR-corrected at
p b .05 are shown. The coordinates refer to the Talairach reference space.4. Discussion
To our knowledge, this is the ﬁrst study to focus on the white
matter volume loss in MSA-P patients as determined by VBM using
SPM8 plus DARTEL. This analysis showed white matter atrophy
in the globus pallidi and external capsules bilaterally extending to
the midbrain. The white matter atrophy also spreads upward to the
subcortical to right premotor area. These areas correspond to the
regions connecting the pathologically affected structures. Such ﬁnd-
ings, which seemed to reﬂect the degeneration of the motor pathway,
have never been presented in previous VBM studies. We believe that
the evaluation of white matter as well as deep gray matter has signif-
icantly improved owing to this new software.
Neuropathological studies have shown neuronal loss and reactive
gliosis in the putamen, caudate nucleus, external pallidum, substantia
nigra, locus coeruleus, inferior olives, pontine nuclei, cerebellar lobes
and intermediolateral cell columns of the spinal cord in MSA-P
(Wenning et al., 1997). Most severe neuronal loss was found in the lat-
eral part of the substantia nigra and dorsolateral putamen (Jellinger et
al., 2005; Ozawa et al., 2004; Wenning et al., 2002). The previous VBM
studies have reported graymatter loss in the putamen, caudate nucleus,
Fig. 2. Comparison of white matter volume by VBM using SPM8 plus DARTEL among 20 patients with MSA-P and 30 control subjects. Signiﬁcant atrophy is observed in the bilateral
globus pallidi and external capsules extending to the midbrain. On the right side, the atrophy extends upward to the subcortical to precentral area through the internal capsule.
White matter atrophy in the pons, bilateral middle cerebellar peduncles and left cerebellum is also detected. Results are superimposed on the customized white matter template
(FDR-corrected at p b .05).
Table 4
Clusters of gray matter loss (14 left-side dominant onset MSA-P vs. 30 controls).
Region volume
(mm3)
Z
score
Talairach coordinates (x, y,
z)
Location of local
maxima
6864 6.38 26, 14, 5 Right putamen
Voxel size 2 × 2 × 2 mm3. Clusters of gray matter SPM analysis with FDR-corrected at
p b .05 are shown. The coordinates refer to the Talairach reference space.
494 Y. Shigemoto et al. / NeuroImage: Clinical 2 (2013) 491–496cerebellar vermis and lobes, dorsal midbrain, and several cortical re-
gions including the insular cortex and motor area (Brenneis et al.,
2003, 2007; Chang et al., 2009; Minnerop et al., 2007, 2010; Tir et al.,
2009; Tzarouchi et al., 2010). The signiﬁcant putaminal loss detected
in our study conﬁrmed the ﬁndings of previous region of interest
based morphometric and VBM studies (Brenneis et al., 2003, 2007;
Minnerop et al., 2007; Schulz et al., 1999; Tzarouchi et al., 2010). OurFig. 3. Comparison of gray and white matter volumes by VBM using SPM8 plus DARTEL amo
gray matter atrophy which is shown in a yellow color is observed only on the right side of th
in a red color is observed only on the right side of the globus pallidus and external capsuleVBM results also agree with the pathological features (Jellinger et al.,
2005; Ozawa et al., 2004; Wenning et al., 1997, 2002).
Though some previous VBM studies have detected the atrophy of
the caudate nucleus (Brenneis et al., 2003; Chang et al., 2009;
Tzarouchi et al., 2010), our study did not detect volume loss in the
caudate nucleus. Pathologically, the caudate nucleus is less involved
than the putamen and tends to be relatively preserved in the early
stage of MSA-P (Ozawa et al., 2004; Wenning et al., 2002). (Chang
et al., 2009) reported that the caudate nucleus had signiﬁcant atrophy
compared to the putamen, a ﬁnding that is inconsistent with patho-
logical features mentioned above. It is possible that the localization
of deep gray matter at the periventricular space made it difﬁcult to
segment the MRIs in older versions of SPM. The recent report of
Messina et al. (2011) supported our ﬁnding of no signiﬁcant volume
loss in the caudate nucleus as measured automatically by FreeSurfer.
Gray matter volume loss in the olivopontocerebellar system can
also be seen in MSA-P, although the degree of involvement is lowerng 14 patients with left-side dominant onset MSA-P and 30 control subjects. Signiﬁcant
e putamen (FDR-corrected at p b .05). Signiﬁcant white matter atrophy which is shown
(FDR-corrected at p b .05).
Table 5
Clusters of white matter loss (14 left-side dominant onset MSA-P vs. 30 controls).
Voxel size 2 × 2 × 2 mm3. Clusters of gray matter SPM analysis with FDR-corrected
at p b .05 are shown. The coordinates refer to the Talairach reference space.
Region volume
(mm3)
Z score Talairach coordinates
(x, y, z)
Location of local
maxima
13,448 5.51 32, −8, 4 Right external capsule
4.93 18, 0, −5 Right lateral globus pallidus
Table 6
Clusters of gray matter loss (6 right-side dominant onset MSA-P vs. 30 controls).
Region volume
(mm3)
Z score Talairach coordinates
(x, y, z)
Location of local
maxima
11,832 5.76 −27, 6, 5 Left putamen
3.76 −61, −5, 8 Left superior temporal gyrus
3.70 −36, −9, 13 Left insula
11,216 4.84 12, −7, 45 Right cingulate gyrus
4.52 2, 17, 34 Right cingulate gyrus
4.18 −12, −8, 43 Left cingulate gyrus
5536 3.76 20, −70, −8 Right lingual gyrus
3.62 24, −76, −11 Right fusiform gyrus
3.55 38, −54, −26 Right cerebellum
4504 3.86 −18, −86, −11 Left fusiform gyrus
3.50 −36, −58, −24 Left cerebellum
Voxel size 2 × 2 × 2 mm3. Clusters of gray matter SPM analysis with FDR-corrected at
p b .05 are shown. The coordinates refer to the Talairach reference space.
Table 7
Clusters of white matter loss (6 right-side dominant onset MSA-P vs. 30 controls).
Region volume
(mm3)
Z score Talairach coordinates
(x, y, z)
Location of local
maxima
101,384 6.05 −34, −10, 2 Left external capsule
5.68 −22, −6, −6 Left lateral globus pallidus
4.79 22, −49, −19 Right cerebellum
4912 4.06 22, −32, 0 Right external capsule
3.88 34, −12, 2 Right external capsule
3.65 24, −8, −10 Right parahippocampal area
4288 4.08 30, 5, 26 Right frontal lobe
3.97 46, 5, 20 Right frontal lobe
3.71 28, −2, 41 Right frontal lobe
Voxel size 2 × 2 × 2 mm3. Clusters of gray matter SPM analysis with FDR-corrected at
p b .05 are shown. The coordinates refer to the Talairach reference space.
495Y. Shigemoto et al. / NeuroImage: Clinical 2 (2013) 491–496than in MSA-C (Wenning et al., 1996, 1997). Atrophy of the cerebellar
vermis and lobes was detected, which is in line with previous VBM
studies (Chang et al., 2009; Minnerop et al., 2010; Tzarouchi et al.,
2010) and pathological ﬁndings (Wenning et al., 1997). White matter
cerebellar atrophy was also detected in addition to gray matter atro-
phy. The pons, bilateral middle cerebellar peduncles and the left
cerebellar lobe were involved, a ﬁnding that was also consistent
with previous VBM studies (Minnerop et al., 2010; Tzarouchi et al.,
2010).
The white matter loss was detected in bilateral globus pallidi and
external capsules extending to the midbrain which has never been
reported before in a study using VBM. The white matter volume loss
of the globus pallidus might reﬂect the fact that the globus pallidus
has many efferent ﬁbers and many bundles of myelinated ﬁbers
from the striatum traverse globus pallidus (Mamata et al., 2002;
Nieuwenhuys et al., 2008). It is supported by the fact that the glucose
metabolism of the globus pallidus is generally almost equal to white
matter metabolism.
The areas connecting the globus pallidus with each structure were
also signiﬁcantly atrophic in this study. The neuronal loss in globus
pallidus is pathologically proven (Jellinger et al., 2005; Ozawa et al.,
2004; Wenning et al., 1997, 2002) and it plays an important role in
parkinsonism as well as substantia nigra. Thus, those ﬁndings could
result from the degeneration of themotor pathway such as striopallidalFig. 4. Comparison of gray and white matter volumes by VBM using SPM8 plus DARTEL amon
gray matter atrophy which is shown in a yellow color is observed in the left putamen, bilat
bellums and several cortical regions are partly shown. Signiﬁcant white matter atrophy whi
sules, right frontal lobe, parahippocampal area and cerebellum (FDR-corrected at p b .05).ﬁber, strionigral ﬁber and pallidonigral ﬁber (Nieuwenhuys et al.,
2008). On the right side, the white matter volume loss extended up-
ward to the subcortical to precentral area. The involvement of the
precentral area could be explained by the fact that the motor cortex,
the supplementary motor cortex and the premotor area were also
involved in the pathways mentioned above; the afferent ﬁbers of the
striatum originate mainly from the motor and premotor areas, and
then go back to the area (Nieuwenhuys et al., 2008). Another possibility
is that the corticospinal tract itself is affected by this disease. The recent
VBM studies of Minnerop et al. (2010) revealed white matter reduction
along the corticospinal tract in the bilateral internal capsules and
subcortical to left precentral gyrus, ﬁndings that agree with our study.
However, they did not detect white matter atrophy around the deep
gray matter. We believe that this was because they evaluated MSA
patients including bothMSA-C andMSA-P patients, andMSA-C patients
made up more than 70% of their patient groups.
This better detection of deep gray matter and white matter
volume loss in our study probably resulted from the application of
the SPM8 plus DARTEL algorithm (Matsuda et al., 2012). The latest
version of SPM8 enabled more accurate segmentation of the MRIs
into gray matter, white matter, and cerebrospinal ﬂuid images com-
pared to older versions of SPM. In addition, DARTEL provides im-
proved registration accuracy compared with conventional VBM.
In this study, we also evaluated both 14 left-side dominant and 6
right-side dominant onset MSA-P patients and detected the contralat-
eral putaminal atrophy. Our results agreed with the previous MR
imaging and pathological ﬁndings (Fearnley and Lees, 1990; Kato et
al., 1992; Kume et al., 1992). The reduced white matter was also
predominant in the contralateral globus pallidus and external capsule
extending to the level of the midbrain. To our knowledge, this is also
the ﬁrst report to mention the laterality of the clinical ﬁndings and of
white matter volume loss using VBM. The detection of volume loss
only on the right side in the corona radiate of 20 MSA-P patients
might be due to the large number of left-side dominant patients.
This study has several limitations. First, the number of patients in
this study was not large. This might be the main reason for the failureg 6 patients with right-side dominant onset MSA-P and 30 control subjects. Signiﬁcant
eral cerebellums and several cortical regions (FDR-corrected at p b .05). Bilateral cere-
ch is shown in a red color is observed in the left globus pallidus, bilateral external cap-
496 Y. Shigemoto et al. / NeuroImage: Clinical 2 (2013) 491–496of detecting the correlation with disease duration and severity. A few
previous VBM studies with a small number of patients have reported
inconsistent results on correlation with disease duration and severity
(Brenneis et al., 2007; Minnerop et al., 2007, 2010). A further study
with a large number of MSA-P patients would be necessary. Second,
this study lacked the pathologic conﬁrmation. However, it was difﬁ-
cult to select data only for pathologically conﬁrmed patients, and
the diagnosis in this study was clinically evaluated by an experienced
neurologist based on consensus criteria. Third, we failed to detect the
gray matter volume loss of the substantia nigra as well as in previous
VBM studies, although the neuronal loss of substantia nigra is a hall-
mark of MSA-P (Mamata et al., 2002; Minnerop et al., 2010; Tir et al.,
2009). Even though the software used for the analysis and the evalu-
ation of spatial resolution have greatly improved, the segmentation of
MRIs of nuclei located in brainstem remains a weakness.
5. Conclusions
In conclusion, VBM using SPM8 plus DARTEL detected signiﬁcant
volume loss not only in the gray but also in the white matter of the
area affected by MSA-P. Signiﬁcant structural atrophic change of the
areas connecting the globus pallidus with each structure which
plays a crucial role in parkinsonism was detected for the ﬁrst time
using VBM. Further prospective investigations involving a larger
number of MSA-P patients combined with DTI techniques are re-
quired to conﬁrm our ﬁndings. VBM using SPM8 plus DARTEL could
also be a useful tool for evaluating other neurodegenerative diseases
as well as MSA-P.
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